CVS Caremark Sees Growth In Generic Drug Switches With Co-pay Waivers
Executive Summary
CVS Caremark, working with State Farm Insurance plan members, found that offering a waiver of generic drug co-payments led to more switches to generics from their brand equivalents and that plan members were more likely to remain on the generic drug after the switch was made
You may also be interested in...
Chart: Timeline Of Pharma Provisions In Health Care Reform
It is arranged in seven sections, with provisions in each arranged chronologically. If the date is listed as "upon enactment," it means no date was specified in the statute; however, in many cases, regulatory agencies may need to issue guidance or regulations before the provision can be implemented. The information is based on the two health care reform bills: H.R. 3590, which contains the bulk of the reform language, passed the Senate in December, passed the House March 21, and was signed into law March 23; and subsequent fixes in the budget reconciliation bill, H.R. 4872, which cleared the House March 21 and Senate March 25, and the president was expected to sign March 30. The chart also borrows from a comparison chart of pharma provisionsin the two bills by Ian Spatz of Manatt, Phelps & Phillips.
CVS Caremark Launches Research Partnership To Improve Rx Adherence
CVS Caremark is working with academic leaders from Carnegie Mellon University, Dartmouth College's Tuck School of Business, and the University of Pennsylvania's Medical School and the Wharton School of Business in an effort to help boost medication adherence for those suffering from chronic conditions
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011